We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04346368
Recruitment Status : Unknown
Verified April 2020 by ShiYue Li, Guangzhou Institute of Respiratory Disease.
Recruitment status was:  Not yet recruiting
First Posted : April 15, 2020
Last Update Posted : April 15, 2020
Guangzhou Eighth People's Hospital
Tongji Hospital
Guangzhou Cellgenes Biotechnology Co.,Ltd
Information provided by (Responsible Party):
ShiYue Li, Guangzhou Institute of Respiratory Disease

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020